By stimulating PDH in cancer cells to normalize glucose metabolism, it can restore their sensitivity to anoikis and weaken their metastatic potential, suggesting that PDKs are potential targets for anti-metastasis therapy (261). This evidence concerns the gene PDP1 and cancer.